Resources

Explore our online resource catalog to discover publications, presentations, tools, and related resources for global health practitioners, decision-makers, advocates, and more.

All resources

Read our latest

2342 Result s
2342 Result s
    Date
    From
    To
  1. This is the story of how PATH and our partners have supported the development of Tanzania's national pediatric tuberculosis (TB) guidelines to help health care workers at all levels of the health system better diagnose, treat, and cure children suffering from TB. This story is one of a series of success stories that showcase some of the ways that PATH’s work in TB is having an impact on people’s lives in a variety of settings around the world. This work was made possible through generous funding from the US Agency for International Development.
    Published: March 2014
    Resource Page
    Part of a Series
  2. This guide was created to support ministries of health and nongovernmental implementing partners as they develop communications strategies related to the introduction of the injectable contraceptive Sayana® Press. The document outlines communication strategies, audiences, key messages, and communications channels recommended for successful introduction of the product. For more information visit the DMPA-SC: Expanding contraceptive access and options page or email FPoptions@path.org.
    Published: February 2014
    Resource Page
    Training Material
  3. This report describes how PATH, in collaboration with partners, undertakes distinct activities at each phase of the value chain—from research to scale-up—to shape the global market for basic neonatal resuscitation equipment for developing countries, as well as some potential risks and mitigation plans going forward.
    Published: February 2014
    Resource Page
    Part of a Series
  4. PATH has developed a low-cost and straightforward approach for protecting aluminum-adjuvanted vaccines from irreversible damage that results from freezing. Many current vaccines of importance to global health contain an aluminum-salt adjuvant (such as aluminum hydroxide or aluminum phosphate) and could benefit from this freeze-protection technology. There is no intellectual property barrier for manufacturers wishing to adopt the technology; it has been placed in the public domain. This technical dossier summarizes the rationale for freeze protection, application of the technology to specific vaccines, the data obtained to date, and comments on the likely regulatory pathway for vaccines incorporating the technology.
    Published: February 2014
    Resource Page
  5. Part of the Technology Updates series, this fact sheet describes PATH's work to develop and deploy OpenLMIS, a community-focused initiative to improve health commodity supply chains, including an open-source, electronic logistics management information system. Find out more about PATH's work in digital health solutions.
    Published: February 2014
    Resource Page
    Part of a Series